Sten Andréasson Selected Research

Sten Andréasson Research Topics

Disease

6	Retinitis Pigmentosa (Pigmentary Retinopathy) 11/2016 - 12/2004
5	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 07/2010
4	Retinal Detachment (Retinal Detachments) 01/2022 - 01/2007
3	Cataract (Cataracts) 01/2022 - 04/2016
3	Retinal Degeneration 09/2016 - 12/2003
3	Glaucoma 04/2016 - 04/2010
2	Vision Disorders (Hemeralopia) 01/2023 - 02/2010
2	Vitreous Detachment (Posterior Vitreous Detachment) 04/2016 - 03/2011
2	Retinal Perforations 04/2016 - 12/2014
2	Vitelliform Macular Dystrophy 02/2016 - 11/2011
1	Retinal Dystrophies 01/2023
1	type 1 Stickler syndrome 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 10/2017
1	Neurologic Manifestations (Neurological Manifestations) 10/2017
1	Color Vision Defects (Color Blindness) 01/2017
1	Atrophy 01/2017
1	Inflammation (Inflammations) 04/2016
1	Ocular Paraneoplastic Syndromes 01/2016
1	Hemangioblastoma 06/2014
1	von Hippel-Lindau Disease (von Hippel Lindau Disease) 06/2014
1	Neovascular Glaucoma 07/2012
1	Retinal Vein Occlusion 07/2012
1	Angle-Closure Glaucoma (Glaucoma, Angle Closure) 11/2011
1	Eye Diseases (Eye Disease) 01/2011
1	Hearing Loss (Hearing Impairment) 01/2011
1	Usher Syndromes (Usher Syndrome) 01/2011
1	Retinoschisis (Retinoschisis, Juvenile) 09/2010
1	Ganglion Cysts (Ganglion) 02/2010
1	Giant Axonal Neuropathy 06/2009
1	Cone-Rod Dystrophies 03/2009
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 03/2009
1	Melanoma (Melanoma, Malignant) 03/2008
1	Alstrom Syndrome 01/2008
1	Leber Congenital Amaurosis 12/2006
1	Leukemia 12/2006
1	Edema (Dropsy) 09/2005
1	Diabetic Retinopathy (Retinopathy, Diabetic) 09/2004
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2004
1	Arthritis (Polyarthritis) 02/2004
1	Retinal Diseases 10/2003

Drug/Important Bio-Agent (IBA)

23	Retinaldehyde (Retinal)IBA 01/2022 - 10/2003
3	Proteins (Proteins, Gene)FDA Link 09/2016 - 12/2006
2	Bevacizumab (Avastin)FDA Link 07/2012 - 07/2010
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	CollagenIBA 01/2021
1	methyl 2- O- alpha- rhamnopyranosyl- beta- galactopyranosideIBA 01/2021
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 11/2016
1	Type 6 Cyclic Nucleotide PhosphodiesterasesIBA 11/2016
1	Silicone OilsIBA 04/2016
1	aryl hydrocarbon receptor-interacting proteinIBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 03/2013
1	acceleratory factor from growth hormone (AcG)IBA 11/2011
1	Ataxin-7IBA 03/2009
1	AutoantibodiesIBA 03/2008
1	BestrophinsIBA 03/2008
1	NucleotidesIBA 12/2006
1	Inosine Monophosphate (IMP)IBA 09/2005
1	Oxidoreductases (Dehydrogenase)IBA 09/2005
1	Methotrexate (Mexate)FDA LinkGeneric 02/2004

Therapy/Procedure

4	Vitrectomy 04/2016 - 01/2010
2	Therapeutics 01/2023 - 01/2017
2	Aftercare (After-Treatment) 10/2017 - 07/2012
2	Intravitreal Injections 07/2012 - 07/2010
2	Scleral Buckling 01/2010 - 01/2007
1	Hematopoietic Stem Cell Transplantation 10/2017
1	General Anesthesia 01/2011
1	Filtering Surgery 04/2010
1	Trabeculectomy (Trabeculoplasty) 04/2010
1	Light Coagulation 09/2004